Aspire Mining (ASX: AKM) locks in $70m EPC deal for Ovoot project infrastructure, targets first coal by Q4 2027
Aspire Mining secures US$69.9M EPC deal for its Mongolian coal project. Find out how this de-risks development and sets the stage for first exports by 2027.
Can GSK’s Exdensur transform asthma biologics with just two doses per year?
GSK’s Exdensur is now FDA approved as the first biannual biologic for severe asthma. Explore what this means for rivals, payers, and global strategy.
Bristol Myers Squibb signs $1.1bn multi-specific antibody discovery deal with Harbour BioMed
Harbour BioMed signed a $1.125B discovery deal with Bristol Myers Squibb to co-develop multi-specific antibodies. Read the full strategic breakdown now.
Cannabis consolidation: Vireo Growth doubles down on Colorado in $49m PharmaCann deal
Vireo Growth acquires 17 PharmaCann dispensaries in Colorado for $49 million in stock. Explore what this bold consolidation move means for U.S. cannabis retail.
Dividend pressure or capital discipline? What Robert Salisbury’s CFO promotion at EPRT really means
Essential Properties Realty Trust appoints Robert Salisbury as CFO. Find out what this signals for REIT strategy, dividend focus, and capital markets execution.
Mark Patten named CFO of Sun Communities as company sharpens financial focus amid REIT sector challenges
Sun Communities names Mark Patten as CFO to sharpen financial strategy in 2026. Explore what this move means for capital discipline and REIT sector positioning.
Can Norgine turn Vir Biotechnology’s hepatitis D duo into a regional blockbuster? €550m deal signals big bet
Vir Biotechnology licenses its hepatitis D therapy to Norgine in a €550M deal. Find out what this means for commercialization, access, and biotech strategy.
Medline’s $6.26bn IPO marks turning point for medical supply sector capital flows
Medline raised $6.26B in 2025’s biggest IPO, aiming to cut debt and expand operations. Find out what this means for investors, rivals, and the IPO market.
Agnico Eagle Mines backs Gaspé Copper and Pine Point with new C$12.48m investment in Osisko Metals
Agnico Eagle Mines invests C$12.48M in Osisko Metals to deepen critical mineral exposure. Find out how this aligns with copper, zinc, and energy transition trends.
Can MetaX deliver on China’s dream of GPU independence after blockbuster IPO?
MetaX shares surged 700% in its IPO as China doubles down on AI chip independence. Find out what this means for Nvidia, AMD, and the global GPU race.